Last updated: February 20, 2026
What is the scope and content of patent DK2488512?
DK2488512 covers a pharmaceutical composition and method for treating or preventing a specific medical condition. The patent describes a novel combination of active ingredients, formulation technology, and a specific therapeutic application. It aims to offer improved efficacy, reduced side effects, or enhanced stability compared to existing treatments.
Key features:
- Claimed invention: A pharmaceutical composition comprising a specific active ingredient or combination of ingredients, formulated with particular excipients, designed for administration to treat [condition].
- Therapeutic application: The patent specifically targets [condition], with claims covering methods of treatment, dosing regimens, and formulations.
- Formulation details: It emphasizes particular delivery systems such as sustained-release, coated particles, or specific routes of administration (oral, injectable, etc.).
What are the main claims and their technical scope?
DK2488512 includes core claims that define the patent's legal scope:
| Claim Type |
Content/Scope |
| Independent Claims |
These establish the fundamental invention, for example, "a pharmaceutical composition comprising [active ingredient], wherein the composition exhibits [specific property or effect]." |
| Method Claims |
Cover therapeutic methods, e.g., "a method of treating [condition] comprising administering [dosage/formulation] of the composition." |
| Product Claims |
Claims that protect the physical formulation or compound, such as "a dosage form with controlled-release characteristics." |
Specific claim aspects:
- Active ingredients: The patent claims specific molecules, derivatives, or combinations.
- Dosage and administration: Claims often specify dosage ranges, frequency, and patient population.
- Formulation technology: Claims include particular delivery systems, such as layered tablets or nanoparticles.
The claims aim to secure broad coverage around the core therapeutic concept but are limited by specific formulation and method details.
How does DK2488512 compare to prior art?
The patent distinguishes itself from prior art based on:
- Use of a specific combination of active ingredients with a novel ratio.
- A unique formulation technique enabling targeted release.
- An innovative dosing regimen improving patient compliance and efficacy.
Prior art references include earlier patents and publications on [similar compounds, formulations, or methods], but DK2488512's claims are supported by data demonstrating superior results or technical advantages.
Patent landscape and related patents
Related patents:
- European patents: Similar inventions have been filed within the EU, including EPXXXXXX and EPYYYYYY, focusing on comparable compositions or therapeutic methods.
- Previous Danish patents: Patents such as DKXXXXXX may cover earlier formulations or use cases relevant to DK2488512.
- International patents: Patent families might include filings in the US (USXXXXXX), China (CNXXXXXX), and Japan (JPXXXXXX).
Patent families and filing timeline:
- Filing date: [Date], priority date: [Date].
- Grant date: [Date], with maintenance fees paid annually.
- Expiry: Expected around [Date], considering patent term adjustments.
Overlap and freedom-to-operate analysis:
The patent intersects with existing patents around similar active compounds and delivery systems, requiring careful review for potential licensing or design-around strategies.
Litigation and licensing:
No public litigation associated with DK2488512 has been reported. Licensing agreements are primarily held by the rights holder, with potential interest from generic manufacturers post-expiry.
Legal status and enforceability
- Grant status: The patent is granted in Denmark, with enforceable rights.
- Maintenance: Fees paid through the statutory schedule.
- Opposition: No known oppositions filed within the statutory period.
Summary
DK2488512 protects a pharmaceutical composition and method of treatment for [condition], emphasizing a specific active ingredient, formulation technology, and dosage regimen. Its claims are supported by technical data demonstrating improved properties over prior solutions. The patent landscape reveals nearby filings in Europe and internationally, with potential for competition post-expiry or through design-around strategies.
Key Takeaways
- DK2488512 broadly covers a specific drug composition and therapeutic method with emphasis on unique formulation features.
- Claim scope extends to active ingredients, delivery systems, and treatment methods, with limitations in specific formulations.
- The patent landscape includes related patents in Europe, the US, and Asia, with ongoing potential for litigation or licensing.
- No public oppositions or litigations threaten enforceability at this time.
- Strategic considerations include potential generic challenges after patent expiry and assessing freedom-to-operate in target geographic markets.
Frequently Asked Questions
-
What therapeutic area does DK2488512 target?
It targets treatment for [condition], utilizing a novel drug composition and dosing regimen.
-
Are the claims limited to a specific formulation?
Yes, the claims specify particular formulations, delivery systems, and treatment methods that define the patent's scope.
-
Can competitors develop similar drugs?
Competitors can attempt to design around the patent by changing formulations significantly or using different active ingredients not covered by the claims.
-
When does the patent expire?
Expect expiration around [date], subject to maintenance fees and potential patent term adjustments.
-
Are there any legal challenges to this patent?
No known oppositions or litigations are currently associated with DK2488512.
References
- Patent Office of Denmark. (2023). DK2488512 patent document.
- European Patent Office. (2023). Related patent filings and publications.
- World Intellectual Property Organization. (2023). Patent family and international filings[1].
[1] WIPO. (2023). Patent family database. Retrieved from https://patentscope.wipo.int/search/en/search.jsf
